Evidence map›Paper›PMID 40543066›Full record

ArticleThe international journal of medical robotics + computer assisted surgery : MRCAS2025

Clinical and Economic Assessment of Robot-Assisted Radical Prostatectomy With the Hinotori Surgical System: Insights From a Japanese Single-Centre Study.

Kotaro Obayashi, Jun Akatsuka, Takuya Nishino, Mami Takadate, Hiroya Hasegawa, Hikaru Mikami, Hayato Takeda, Yuki Endo, Yuka Toyama, Takeshi Yamada and 3 more

Abstract readClinical Study
In one paragraph

Article in The international journal of medical robotics + computer assisted surgery : MRCAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kotaro ObayashiDepartment of Urology, Nippon Medical School, Tokyo, Japan.
Jun AkatsukaDepartment of Urology, Nippon Medical School, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2671-7064
Takuya NishinoDepartment of Health Care Administration, Nippon Medical School, Tokyo, Japan.
Mami TakadateDepartment of Urology, Nippon Medical School, Tokyo, Japan.
Hiroya HasegawaDepartment of Urology, Nippon Medical School, Tokyo, Japan.
Hikaru MikamiDepartment of Urology, Nippon Medical School, Tokyo, Japan.
Hayato TakedaDepartment of Urology, Nippon Medical School, Tokyo, Japan.
Yuki EndoDepartment of Urology, Nippon Medical School, Tokyo, Japan.
Yuka ToyamaDepartment of Urology, Nippon Medical School, Tokyo, Japan.
Takeshi YamadaDepartment of Digestive Surgery, Nippon Medical School, Tokyo, Japan.
Yoichiro YamamotoPathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan.
Go KimuraDepartment of Urology, Nippon Medical School, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0088-9324
Yukihiro KondoDepartment of Urology, Nippon Medical School, Tokyo, Japan.ORCID https://orcid.org/0000-0003-4141-9230

Funding

JST Moonshot R&D JPMJMS2022MEXT KAKENHI 23K17235MEXT KAKENHI 24K12449Sysmex Corporation
6 · The paper itself

Abstract

backgroundWe investigated the clinical and economic outcomes of robot-assisted radical prostatectomy (RARP) using the hinotori surgical system (H-RARP).

methodsThe analysis was conducted on 76 and 68 patients who underwent RARP using the da Vinci surgical system (D-RARP) and H-RARP, respectively. Safety, oncological, and functional outcomes were compared between H-RARP and D-RARP. Risk factors influencing medical costs in RARP were identified via linear regression analysis.

resultsExcept for longer operative time in H-RARP, clinical outcomes were comparable. The median medical costs per case were $12,426.8 for D-RARP and $12,548.9 for H-RARP. Operative time (coefficient: 0.0002, p < 0.001), pathological T stage (coefficient: 0.023, p = 0.030), and postoperative hospital stay (coefficient: 0.028, p < 0.001) were significant factors affecting medical costs; in contrast, the type of robot-assisted surgical system was not a significant factor.

conclusionsH-RARP offers clinical outcomes comparable to those of D-RARP while maintaining equivalent medical costs.

Indexed as

ProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresAgedHumansJapanLength of StayMaleMiddle AgedOperative TimeRisk FactorsTreatment Outcomecostsonco‐urologyprostatectomyrobotic surgery

Identifiers

PMID40543066
PMCPMC12182272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.